The Neurological Field Continues to Update
In recent years, there has been tremendous growth in new diagnostic information, pharmacological and neurosurgical treatments for neurological disease, as well as a greater understanding of brain function. Our news section informs you of ongoing topics with a potential worldwide influence. In addition to this section, we inform through our social media platforms to keep connect with our member more easier than before.
Our subcategories on News include:
- World Federation of Neurology News
We inform you on our projects and activities, the journal updates, the WFN committee update and more... - Neurology News
Update on interesting news and current activities with worldwide scope. From the history of neurology through the modern technology that shape neurology nowadays.
World Federation of Neurology News
3 Apr 2026
Journal of the Neurological Sciences issue 484 now available
18 Mar 2026
WFN Training Centre: One-Year Visiting Fellow Program in Cairo
13 Mar 2026
eNeurologicalSci (eNS) March 2026 issue
Neurology News
5 Apr 2026
Association of symptoms of neuropsychological long COVID with imaging and plasma biomarkers
This study explores the neurological mechanisms behind “brain fog” and other cognitive symptoms associated with Long COVID by analysing brain imaging and blood biomarkers in affected patients. Using MRI, cerebral blood flow imaging, and a range of neuropsychological tests, researchers identified associations between cognitive performance, anxiety and depression scores, and changes in blood flow in specific brain regions, particularly the occipital and parietal lobes.
3 Apr 2026
Journal of the Neurological Sciences issue 484 now available
Vol. 484, May 2026 now available
28 Mar 2026
The immune awakening: Transformative strategies against brain tumors
This review highlights how GBM exploits mechanisms such as MHC downregulation, immunosuppressive cytokine secretion, metabolic reprogramming, and recruitment of Tregs and myeloid-derived suppressor cells, reinforced by tumor heterogeneity and the blood–tumor barrier.
